Actively Recruiting
An Open-label Phase II/III Randomized Trial of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Monotherapy as First Line Therapy in Patients With Unresectable Recurrent or Metastatic HPV16-Positive Head and Neck Squamous Cell Carcinoma Expressing PD-L1
Led by BioNTech SE · Updated on 2026-05-22
350
Participants Needed
195
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the safety, tolerability, and effectiveness of BNT113 combined with pembrolizumab compared to pembrolizumab alone as a first treatment for patients with unresectable recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) that tests positive for human papillomavirus 16 (HPV16) and expresses the protein PD-L1. This Phase II/III trial includes patients whose tumors have a combined positive score of 1 or higher for PD-L1. The study is designed to generate important safety and efficacy data for these treatments in this patient group. The trial consists of two parts: Part A is a non-randomized safety run-in phase to confirm the safety and tolerability of BNT113 with pembrolizumab. Part B is a randomized phase comparing BNT113 combined with pembrolizumab versus pembrolizumab alone. Treatments are given by intravenous injection or infusion. Patients may receive treatment for up to 24 months. An optional pre-screening phase allows tumor samples to be tested centrally for HPV16 DNA and PD-L1 expression before entering the main trial. Participants will undergo regular assessments including monitoring for treatment-emergent adverse events, overall survival, and progression-free survival for up to 48 months. Researchers will also measure response rates and duration, disease control, and any dose adjustments due to side effects. Patients provide tumor tissue samples before treatment and are monitored closely throughout the study period. The trial aims to collect comprehensive data on safety, treatment effects, and patient outcomes over this extended follow-up.
CONDITIONS
Brief Title
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Histologically confirmed recurrent or metastatic HPV16-positive head and neck squamous cell carcinoma considered incurable by local therapies
- Tumor expresses PD-L1 with a combined positive score of 1 or higher as determined by approved testing
- No prior systemic anticancer therapy in the incurable recurrent or metastatic setting; prior therapy completed more than 180 days before randomization is allowed if part of multimodal treatment for locally advanced disease
- Measurable disease based on RECIST 1.1 criteria
- Provision of tumor tissue sample from archival tissue or fresh biopsy preferably from a current metastatic or recurrent site
You will not qualify if you...
- Primary tumor site is nasopharynx of any histology
- Another primary malignancy not in complete remission for at least 2 years, except certain low-risk cancers
- Chronic systemic immunosuppressive treatment exceeding prednisone 10 mg daily within 7 days before first trial dose
- Prior treatment with immune-modulating agents within 4 weeks or five half-lives before first BNT113 dose, or unresolved immune-related adverse events
- Prior treatment with live attenuated vaccines within 4 weeks before first BNT113 dose
- Prior investigational drug treatment within 4 weeks or five half-lives before first BNT113 dose
- Ongoing therapeutic oral or intravenous antibiotic treatment (prophylactic antibiotics allowed)
- Prior treatment with anti-cancer immunomodulating agents within 4 weeks or five half-lives before first BNT113 dose
- Non-systemic anti-cancer therapy within 2 weeks prior to randomization (except allowed bone resorptive therapies)
- Other protocol defined criteria may apply
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Duration varies during the safety run-in phase
Participants receive BNT113 in combination with pembrolizumab to confirm safety and tolerability at the selected dose level.
Multiple visits during safety run-in phase
Duration - Up to 48 months
Participants receive either BNT113 combined with pembrolizumab or pembrolizumab alone as first-line therapy for their cancer.
Regular visits for treatment administration and monitoring
Trial Site Locations
Total: 195 locations
1
California Research Institute
Los Angeles, California, United States, 90027
Withdrawn
2
UCLA Cancer Care
Los Angeles, California, United States, 90095
Actively Recruiting
3
Stanford Cancer Institute
Palo Alto, California, United States, 94304
Completed
4
Yale University
New Haven, Connecticut, United States, 06511
Actively Recruiting
5
The George Washington Cancer Center
Washington D.C., District of Columbia, United States, 20052
Actively Recruiting
6
University of Miami Miller School of Medicine
Miami, Florida, United States, 33136
Actively Recruiting
7
University Cancer and Blood Center
Athens, Georgia, United States, 30607
Withdrawn
8
Winship Cancer Institute
Atlanta, Georgia, United States, 30322
Actively Recruiting
9
Norton Cancer Institute
Louisville, Kentucky, United States, 40241
Actively Recruiting
10
Tufts Medical Center
Boston, Massachusetts, United States, 02111
Actively Recruiting
11
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
Actively Recruiting
12
The University of New Mexico Comprehensive Cancer Center
Albuquerque, New Mexico, United States, 87131
Actively Recruiting
13
Memorial Sloan Kettering Cancer Center
Long Island City, New York, United States, 11101
Actively Recruiting
14
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
Actively Recruiting
15
Montefiore Medical Center
The Bronx, New York, United States, 10467
Actively Recruiting
16
University of Cincinnati Cancer Center
Cincinnati, Ohio, United States, 45219
Actively Recruiting
17
Providence Cancer Institute
Portland, Oregon, United States, 97213
Withdrawn
18
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
19
MultiCare Regional Cancer Center
Tacoma, Washington, United States, 98405
Withdrawn
20
Centro de Oncología e Investigación Buenos Aires COIBA
Berazategui, Argentina, B1884BBF
Actively Recruiting
21
Hospital Britanico de Buenos Aires
Ciudad de Buenos Aires, Argentina, 1280
Withdrawn
22
Instituto de Oncologia de Cordoba
Córdoba, Argentina, X500AA1
Actively Recruiting
23
Centro Oncologico Riojano Integral
La Rioja, Argentina, 5300
Actively Recruiting
24
Centro de Investigacion Pergamino SA - Clinica Pergamino
Pergamino, Argentina, 2700
Actively Recruiting
25
Instituto de Oncologia de Rosario
Rosario, Argentina, 2000
Actively Recruiting
26
Sanatorio Britanico
Rosario, Argentina, 2000
Actively Recruiting
27
CAIPO Centro para la Atencion Integral del Paciente Oncologico
San Miguel de Tucumán, Argentina, 4000
Actively Recruiting
28
Clinica Viedma
Viedma, Argentina, 8500
Withdrawn
29
Cancer Research SA
Adelaide, Australia, 5000
Actively Recruiting
30
Bankstown-Lidcombe Hospital
Bankstown, Australia, 2200
Withdrawn
31
Flinders Medical Centre
Bedford Park, Australia, 5042
Actively Recruiting
32
Coffs Harbour Hospital
Coffs Harbour, Australia, 2450
Withdrawn
33
St Vincent's Hospital
Fitzroy, Australia, VIC 3065
Actively Recruiting
34
Royal North Shore Hospital
Saint Leonards, Australia, 2065
Actively Recruiting
35
John Flynn Private Hospital
Tugun, Australia, 4224
Actively Recruiting
36
Southern Medical Day Care Centre
Wollongong, Australia, 2500
Actively Recruiting
37
LKH - Univ. Klinikum Graz
Graz, Austria, 8036
Actively Recruiting
38
Landeskrankenhaus/ Univ.-Kliniken Innsbruck
Innsbruck, Austria, 6020
Actively Recruiting
39
HNO, Kopf-und Halschirurgie Ordensklinikum Linz Barmherzigen Schwestern
Linz, Austria, 4010
Actively Recruiting
40
Uniklinikum Salzburg, Univ. Klinik fur Innere Medizin III
Salzburg, Austria, 5020
Actively Recruiting
41
Universitair Ziekenhuis Brussel
Brussels, Belgium, 1090
Actively Recruiting
42
Universitair Ziekenhuis Gent UZ Gent
Ghent, Belgium, 9000
Actively Recruiting
43
CHR de la Citadelle
Liège, Belgium, 4000
Actively Recruiting
44
Fundação PIO XII - Hospital de Amor Barretos
Barretos, Brazil, 14784-400
Actively Recruiting
45
Oncocentro - Grupo Oncoclinicas
Belo Horizonte, Brazil, 30360-680
Actively Recruiting
46
Fundacao Universidade de Caxias do Sul - Instituto de Pesquisas em Saude IPS-UCS
Caxias do Sul, Brazil, 95070-560
Actively Recruiting
47
Hospital Erasto Gaertner
Curitiba, Brazil, 81520-060
Actively Recruiting
48
Oncosite - Centro de Pesquisa Clinica em Oncologia
Ijuí, Brazil, 98700-000
Actively Recruiting
49
Hospital Marcio Cunha
Ipatinga, Brazil, 35162-189
Actively Recruiting
50
Irmandade Santa Casa de Misericordia de Porto Alegre Hospital Santa Rita
Porto Alegre, Brazil, 90050-170
Actively Recruiting
51
Hospital Mae de Deus
Porto Alegre, Brazil, 90110-270
Actively Recruiting
52
Hospital Sao Lucas da PUCRS
Porto Alegre, Brazil, 90610-000
Actively Recruiting
53
Instituto Nacional de Cancer Jose de Alencar Gomes da Silva - INCA
Rio de Janeiro, Brazil, 20231-050
Actively Recruiting
54
Nucleo de Oncologia da Bahia
Salvador, Brazil, 40170-070
Actively Recruiting
55
Hospital Sao Rafael
Salvador, Brazil, 41253-190
Actively Recruiting
56
Hospital de Base de Sao Jose do Rio Preto
São José do Rio Preto, Brazil, 15090-000
Actively Recruiting
57
Instituto do Cancer do Estado de São Paulo
São Paulo, Brazil, 01246-000
Actively Recruiting
58
IBCC - Instituto Brasileiro de Controle do Cancer
Vila Mariana, Brazil, 04014-002
Actively Recruiting
59
Cross Cancer Institute
Edmonton, Canada, T6G 1Z2
Actively Recruiting
60
British Columbia Cancer Agency
Kelowna, Canada, V1Y 5L3
Actively Recruiting
61
Jewish General Hospital
Montreal, Canada, H3T 1E2
Actively Recruiting
62
McGill University Health Centre
Montreal, Canada, H4A 3J1
Actively Recruiting
63
Princess Margaret Cancer Centre
Toronto, Canada, M5G 2C1
Withdrawn
64
Centro de Estudios Clinicos SAGA
Santiago, Chile, 7500653
Actively Recruiting
65
Fundación Arturo López Pérez
Santiago, Chile, 7500921
Actively Recruiting
66
James Lind Centro de Investigación del Cáncer
Temuco, Chile, 4800827
Withdrawn
67
Fakultni Nemocnice Olomouc
Olomouc, Czechia, 779 00
Actively Recruiting
68
Hospital Na Bulovce (Nemocnice na Bulovce)
Prague 8 - Liben, Czechia, 180 00
Actively Recruiting
69
CHU de BORDEAUX, Hopital Saint Andre
Bordeaux, France, 33075
Actively Recruiting
70
CHU de Caen Normandie
Caen, France, 14033
Actively Recruiting
71
Centre Georges Francois Leclerc
Dijon, France, 21079
Active, Not Recruiting
72
Clinique Victor Hugo
Le Mans, France, 72000
Withdrawn
73
Institut de Radiothérapie Hartmann, GCS CCConcorde
Levallois-Perret, France, 92300
Withdrawn
74
Hopital de la Timone
Marseille, France, 13005
Actively Recruiting
75
Hopital Prive du Confluent
Nantes, France, 44277
Withdrawn
76
Institut Curie
Paris, France, 75005
Actively Recruiting
77
Institut Curie, Groupe Hospitalier Paris Saint-Joseph (GHPSJ)
Paris, France, 75014
Active, Not Recruiting
78
CHU de Tours Hopital Bretonneau
Tours, France, 37044
Actively Recruiting
79
Hospital Gustave Roussy
Villejuif, France, 94800
Actively Recruiting
80
Charite Universitätsklinikum Berlin - Campus Benjamin Franklin
Berlin, Germany, 13353
Actively Recruiting
81
Klinik für HNO-Heilkunde, Kopf- und Hals-Chirurgie
Cologne, Germany, 50937
Actively Recruiting
82
Krankenhaus Nordwest GmbH
Frankfurt am Main, Germany, 60488
Withdrawn
83
SRH Wald-Klinikum Gera GmbH
Hamburg, Germany, 07548
Withdrawn
84
Kath. Marien Krankenhaus gGmbH
Hamburg, Germany, 40878
Withdrawn
85
Medizinische Hochschule Hannover (MHH)
Hanover, Germany, 30625
Actively Recruiting
86
Universitaetsklinik Heidelberg
Heidelberg, Germany, 69124
Actively Recruiting
87
St. Josefs-Hospital, Katholisches Krankenhaus Hagen gem. GmbH
Iserlohn, Germany, 58638
Actively Recruiting
88
Universitätsklinikum Leipzig
Leipzig, Germany, 04103
Actively Recruiting
89
UNIVERSITAETSMEDIZIN der Johannes Gutenberg-Universitaet Mainz
Mainz, Germany, 55131
Actively Recruiting
90
Klinikum rechts der Isar der TUM
München, Germany, 81675
Actively Recruiting
91
Univeritätsklinikum Münster
Münster, Germany, 48149
Actively Recruiting
92
Universitaetsmedizin Rostock - Medizinische Klink III (Hamatologie, Onkologie, Palliativmedizin)
Rostock, Germany, 18057
Actively Recruiting
93
Caritas Klinikum Saarbrucken St. Theresia
Saarbrücken, Germany, 66113
Actively Recruiting
94
Medizinische Universitaetsklinik Tuebingen
Tübingen, Germany, 72076
Actively Recruiting
95
Universitätsklinikum Ulm, Klinik für Hals-Nasen- Ohrenheilkunde und Kopf-Halschirurgie
Ulm, Germany, 89081
Actively Recruiting
96
Universitaetsklinikum Wuerzburg
Würzburg, Germany, 97080
Actively Recruiting
97
Central Hospital of Northern Pest - Military Hospital
Budapest, Hungary, 1062
Actively Recruiting
98
Uzsoki Utcai Korhaz Onkologiai Osztaly
Budapest, Hungary, 1145
Withdrawn
99
DEKK Onkologiai Klinika
Debrecen, Hungary, 4032
Withdrawn
100
Zala Megyei S. Rafael Korhaz
Zalaegerszeg, Hungary, 8900
Actively Recruiting
101
Rambam Health Clinical
Haifa, Israel, 3109601
Actively Recruiting
102
Hadassah Medical Center - Sharett Institute of Oncology
Jerusalem, Israel, 49100
Actively Recruiting
103
Rabin Medical Center
Petah Tikva, Israel, 4941492
Actively Recruiting
104
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel, 6423906
Actively Recruiting
105
ASST Spedali Civili Brescia
Brescia, Italy, 25123
Actively Recruiting
106
Mater Salutis Hospital AULSS 9 della Regione Veneto
Legnago, Italy, 37045
Actively Recruiting
107
IRCCS Ospedale San Raffaele
Milan, Italy, 20132
Actively Recruiting
108
IRCCS Istituto Europeo di Oncologia
Milan, Italy, 20141
Actively Recruiting
109
Ospedale del Mare
Naples, Italy, 80147
Withdrawn
110
A.O.U. Maggiore della Carita
Novara, Italy, 28100
Withdrawn
111
Azienda Ospedaliera Universitaria Senese Policlinico Le Scotte
Siena, Italy, 53100
Actively Recruiting
112
Azienda Sanitaria Universitaria Integrata Friuli Centrale - Presidio ospedaliero di Udine
Udine, Italy, 33100
Withdrawn
113
Centro de Estudios y Prevención del Cáncer (CEPREC)
Tuxtla Gutiérrez, Region Chiapas, Mexico, 29038
Actively Recruiting
114
Centro Estatal de Cancerologia de Chihuahua
Chihuahua City, Mexico, 31000
Actively Recruiting
115
Hospital Civil de Guadalajara Fray Antonio Alcalde
Guadalajara, Mexico, 44280
Actively Recruiting
116
Cryptex Investigacion SA de CV
Mexico City, Mexico, 06100
Actively Recruiting
117
Consultorio del Dr. Joaquín Gabriel Reinoso Toledo
Monterrey, Mexico, 64320
Actively Recruiting
118
Hospital Universitario "Dr Jose Eleuterio Gonzalez" Centro Universitario contra el Cáncer
Monterrey, Mexico, 64460
Actively Recruiting
119
Oaxaca Site Management Organization S. C.
Oaxaca City, Mexico, 68000
Actively Recruiting
120
Sociedad de Metabolismo y Corazón S.C.
Veracruz, Mexico, 91900
Actively Recruiting
121
Centro de Atencion e Investigacion Clinica en Oncologia (CAICO)
Yucatán, Mexico, 97134
Actively Recruiting
122
Uniwersyteckie Centrum Kliniczne
Gdansk, Poland, 80-214
Actively Recruiting
123
Szpitale Pomorskie Sp.zo.o
Gdynia, Poland, 81-519
Withdrawn
124
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie
Gliwice, Poland, 44-102
Actively Recruiting
125
Przychodnia Lekarska KOMED Roman Karaszewski
Konin, Poland, 62-500
Actively Recruiting
126
MCM Pratia Krakow
Krakow, Poland, 30-510
Withdrawn
127
Centrum Medyczne Pratia Poznań
Poznan, Poland, 60-185
Withdrawn
128
Wojskowy Szpital Kliniczny z Poliklinika SP ZOZ
Wroclaw, Poland, 50-981
Actively Recruiting
129
Centro Clinico Academico
Braga, Portugal, 4710-243
Withdrawn
130
Instituto Português de Oncologia de Coimbra Francisco Gentil, E.P.E.
Coimbra, Portugal, 3000-075
Actively Recruiting
131
Centro Hospitalar de Vila Nova de Gaia/Espinho
Gaia, Portugal, 4434-502
Withdrawn
132
IPO Lisboa Francisco Gentil
Lisbon, Portugal, 1099-023
Actively Recruiting
133
Centro Hospitalar Universitario Lisboa Norte
Lisbon, Portugal, 1649-028
Actively Recruiting
134
Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E
Porto, Portugal, 4200-072
Actively Recruiting
135
Chungnam National University Hospital
Daejeon, South Korea, 35015
Withdrawn
136
Konyang University Hospital
Daejeon, South Korea, 35365
Actively Recruiting
137
Chonnam National University Hwasun Hospital
Hwasun, South Korea, 58128
Actively Recruiting
138
Korea University Anam Hospital
Seoul, South Korea, 02841
Actively Recruiting
139
Severance Hospital, Yonsei University Health System
Seoul, South Korea, 03722
Actively Recruiting
140
The Catholic University of Korea, Seoul ST. Mary's Hospital
Seoul, South Korea, 06591
Actively Recruiting
141
The Catholic University of Korea St. Vincent's Hospital
Suwon, South Korea, 16247
Actively Recruiting
142
Ajou University Hospital
Suwon, South Korea, 16499
Actively Recruiting
143
Hospital Clinic Barcelona
Barcelona, Spain, 08036
Actively Recruiting
144
Hospital Univ. Dr. Josep Trueta
Girona, Spain, 17007
Actively Recruiting
145
Complejo Hospitalario de Jaen
Jaén, Spain, 23007
Actively Recruiting
146
Clinica Universidad de Navarra - Madrid (CUN-M)
Madrid, Spain, 28027
Actively Recruiting
147
Hospital Universitario Fundacion Jimenez Diaz
Madrid, Spain, 28040
Actively Recruiting
148
Hospital Universitario La Paz
Madrid, Spain, 28046
Withdrawn
149
Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, Spain, 28222
Actively Recruiting
150
Hospital Regional de Malaga
Málaga, Spain, 29010
Actively Recruiting
151
Hospital Universitario Son Espases
Palma de Mallorca, Spain, 07120
Actively Recruiting
152
Clinica Universidad de Navarra - Pamplona (CUN-P)
Pamplona, Spain, 31008
Actively Recruiting
153
Hospital La Fe
Valencia, Spain, 46026
Actively Recruiting
154
Hospital Miguel Servet
Zaragoza, Spain, 50009
Withdrawn
155
Sahlgrenska University Hospital
Gothenburg, Sweden, 413 45
Withdrawn
156
Skane University Hospital
Lund, Sweden, 221 85
Withdrawn
157
Norrlands University Hospital
Umeå, Sweden, 901 87
Withdrawn
158
Changhua Christian Hospital
Changhua, Taiwan, 50006
Actively Recruiting
159
Chang Bing Show Chwan Memorial Hospital
Changhua, Taiwan, 50544
Actively Recruiting
160
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan, 80708
Actively Recruiting
161
Chang Gung Memorial Hospital-Kaohsiung Branch
Kaohsiung City, Taiwan, 833401
Actively Recruiting
162
Taichung Veterans General Hospital
Taichung, Taiwan, 407219
Actively Recruiting
163
National Taiwan University Hospital
Taipei, Taiwan, 100225
Actively Recruiting
164
Taipei Veterans General Hospital
Taipei, Taiwan, 11217
Actively Recruiting
165
Medical Park Seyhan Hospital
Adana, Turkey (Türkiye), 01140
Withdrawn
166
Hacettepe University Cancer Institute
Ankara, Turkey (Türkiye), 06230
Withdrawn
167
Ankara Bilkent Sehir Hastanesi
Ankara, Turkey (Türkiye), 06800
Withdrawn
168
Trakya University
Edirne, Turkey (Türkiye), 22030
Withdrawn
169
Istanbul Universitesi Onkoloji Enstitusu
Istanbul, Turkey (Türkiye), 34093
Withdrawn
170
Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty
Istanbul, Turkey (Türkiye), 34098
Withdrawn
171
Medipol Mega Universite Hastanesi
Istanbul, Turkey (Türkiye), 34214
Withdrawn
172
Istanbul Medeniyet University Medical Faculty
Istanbul, Turkey (Türkiye), 34722
Withdrawn
173
Ege Universitesi Tip Fakultesi Hastanesi - Tulay Aktas Onkoloji Hastanesi
Izmir, Turkey (Türkiye), 35040
Withdrawn
174
Medical Park - Izmir Hastanesi
Izmir, Turkey (Türkiye), 35575
Withdrawn
175
Inonu Universitesi - Turgut Ozal Tip Merkezi
Malatya, Turkey (Türkiye), 44280
Withdrawn
176
Baskent University
Yüreğir, Turkey (Türkiye), 01250
Withdrawn
177
Aberdeen Royal Infirmary
Aberdeen, United Kingdom, AB25 2ZN
Actively Recruiting
178
Belfast Health and Social Care Trust, Belfast City Hospital
Belfast, United Kingdom, BT9 7AB
Actively Recruiting
179
University Hospitals Birmingham, Queen Elizabeth Hospital
Birmingham, United Kingdom, B15 2TH
Actively Recruiting
180
Addenbrooke's Hospital - Cambridge University Hospitals
Cambridge, United Kingdom, CB2 0QQ
Actively Recruiting
181
Velindre Cancer Centre
Cardiff, United Kingdom, CF14 2TL
Actively Recruiting
182
Beatson West of Scotland Cancer Centre
Glasgow, United Kingdom, G12 0YN
Actively Recruiting
183
Leeds Teaching Hospitals NHS Trust (St James's University Hospital)
Leeds, United Kingdom, LS9 7TF
Actively Recruiting
184
The Clatterbridge Cancer Centre
Liverpool, United Kingdom, L7 8YA
Actively Recruiting
185
University College London Hospitals
London, United Kingdom, NW 12 PG
Actively Recruiting
186
Guy's Cancer Centre, Guy's Hospital
London, United Kingdom, SE1 9RT
Actively Recruiting
187
The Royal Marsden Hospital NHS Foundation Trust - Fulham Road
London, United Kingdom, SW3 6JJ
Actively Recruiting
188
The Christie NHS Foundation Trust
Manchester, United Kingdom, M20 4BX
Actively Recruiting
189
Nottingham University Hospitals NHS Trust
Nottingham, United Kingdom, NG5 1PB
Actively Recruiting
190
Oxford Cancer Centre
Oxford, United Kingdom, OX3 7LE
Actively Recruiting
191
Royal Preston Hospital Lancashire Teaching Hospitals NHS Foundation Trust
Preston, United Kingdom, PR2 9HT
Actively Recruiting
192
University Hospital Southampton NHS Foundation Trust
Southampton, United Kingdom, SO16 6YD
Actively Recruiting
193
Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust
Stevenage, United Kingdom, SG1 4AB
Actively Recruiting
194
The Royal Marsden Hospital - Sutton
Sutton, United Kingdom, SM2 5PT
Actively Recruiting
195
Torbay Hospital - South Devon Healthcare NHS Foundation Trust
Torquay, United Kingdom, TQ2 7AA
Actively Recruiting
Research Team
B
BioNTech clinical trials patient information
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here